Phil is a developer of a Patient Access Platform that aims to leverage tech in a meaningful way to expedite speed-to-therapy. With a mission to offer an enhanced experience for providers and patients, Phil includes PhillRx “smart prescriptions” for patients to connect them with providers to help get patients the therapy consultations they need. Phil was founded by Deepak Thomas and Puran Singh in 2015 and is headquartered in San Francisco, CA.
Funding Date | Share Class | Amount Raised | Price per Share | Post-Money Valuation | Key Investors | |
---|---|---|---|---|---|---|
07/03/2021 | Series D | $56MM | $xx.xx | $300.91MM | Warburg Pincus | |
Price per Share
$xx.xx
Shares Outstanding
13,801,259
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Warburg Pincus
|
||||||
07/01/2020 | Series C | $28.5MM | $xx.xx | $126.84MM | Undisclosed Investors | |
Price per Share
$xx.xx
Shares Outstanding
14,054,690
Liquidation Pref Order
2
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Undisclosed Investors
|
||||||
05/15/2019 | Series B | $19.57MM | $xx.xx | $69.69MM | Crosslink Capital, Greatpoint Ventures, Tarsadia Investments, Uncork Capital | |
Price per Share
$xx.xx
Shares Outstanding
13,917,600
Liquidation Pref Order
2
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Crosslink Capital, Greatpoint Ventures, Tarsadia Investments, Uncork Capital
|
||||||
08/16/2017 | Series A | $7.92MM | $xx.xx | $21.44MM | Crosslink Capital, Eniac Ventures, Forerunner Ventures, Silicon Valley Bank, Softtech Vc, Sv Angel, Transmedia Capital | |
Price per Share
$xx.xx
Shares Outstanding
11,695,527
Liquidation Pref Order
2
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Crosslink Capital, Eniac Ventures, Forerunner Ventures, Silicon Valley Bank, Softtech Vc, Sv Angel, Transmedia Capital
|
||||||
08/07/2015 | Series Seed | $2.11MM | $xx.xx | $6.03MM | Undisclosed Investors | |
Price per Share
$xx.xx
Shares Outstanding
4,125,112
Liquidation Pref Order
2
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Undisclosed Investors
|